S&P/ASX200 (INDEXASX:XJO) feels the rates heat
James Dunn
October 4, 2023
The Australia share market retreated to a six-month low on
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The Australia share market retreated to a six-month low on
It was relatively quiet on the ASX on Monday with
Pro Medicus Limited (ASX: PME) was a standout, adding 12.4%.
There really isn’t a “secret sauce” behind these stories –
The Cochlear Limited (ASX: COH) share price bounced dramatically higher
The CSL Ltd (ASX:CSL) share price is up more than
ResMed CDI (ASX: RMD) shares are trading down about -11%
The CSL Limited (ASX: CSL) share price has fallen below
On The Australian Investors Podcast this week, Owen Rask and
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
